Second Sight Medical (EYES) Reports Q4 Loss of $0.17

Second Sight Medical (NASDAQ: EYES) reported Q4 EPS of ($0.17), versus ($0.19) reported last year. Revenue for the quarter came in at $1.5 million versus the consensus estimate of $600 thousand.

For earnings history and earnings-related data on Second Sight Medical (EYES) click here.

You May Also Be Interested In

• Is Treasury selloff a major issue for stock market bulls?
• Femasys Inc. (FEMY) Misses Q2 EPS by 20c
• The LGL Group (LGL) Misses Q2 EPS by 8c